The single payer form of health insurance for all Americans: could this be the year that the long-debated model for medical care coverage becomes a reality? Dr. David Himmelstein, associate professor of medicine at Harvard Medical School and a long-time advocate of single payer coverage, tells the Chicago Tribune's Bruce Japsen about the best chance in years for this model in the healthcare reform debate.
Single Payer Health Coverage's Fighting Chance
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
The single payer form of health insurance for all Americans: could this be the year that the long-debated model for medical care coverage becomes a reality? Dr. David Himmelstein, associate professor of medicine at Harvard Medical School and a long-time advocate of single payer coverage, tells the Chicago Tribune's Bruce Japsen about the best chance in years for this model in the healthcare reform debate.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
Best Practices for Identifying, Diagnosing and Treating Transthyretin Amyloidosis (ATTR-PN and ATTR-CM)
HF Management for Patients with Comorbid Conditions
Level Up Your Skills: Tailoring Management of HF
Personalizing Care Within the RCC Treatment Paradigm
Navigating Myasthenia Gravis in Adolescents and Young Adults
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?